Piroxicam spares buprenorphine after total joint replacement
DOI:
https://doi.org/10.1080/17453679209169730Abstract
In a blinded, placebo-controlled study, the nonsteroidal antiinflammatory drug piroxicam, in combination with the partial morphine agonist/antagonist buprenorphine, was compared with buprenorphine alone for analgesic effect and side-effects in a 10-day period following total replacement of the hip or knee. 117 patients entered and 81 completed the study. The patients receiving piroxicam consumed less buprenorphine. There were no differences concerning side-effects between the two treatment groups, apart from a tendency towards less nausea after the third postoperative day in the group receiving piroxicam.Downloads
Download data is not yet available.
Downloads
Published
1992-01-01
How to Cite
Boeckstyns, M. E. H., Backer, M., Petersen, E. M., Høj, I., Albrechtsen, H., & Andersen, H. B. (1992). Piroxicam spares buprenorphine after total joint replacement. Acta Orthopaedica, 63(6), 658–660. https://doi.org/10.1080/17453679209169730
Issue
Section
Articles
License
Acta Orthopaedica (Scandinavica) content is available freely online as from volume 1, 1930. The journal owner owns the copyright for all material published until volume 80, 2009. As of June 2009, the journal has however been published fully Open Access, meaning the authors retain copyright to their work. As of June 2009, articles have been published under CC-BY-NC or CC-BY licenses, unless otherwise specified.
PlumX (by Elsevier) is an altmetrics platform that tracks and visualizes the online attention, usage, captures, citations, and social media engagement.
